Could CereVasc Be Boston’s Next Big MedTech Success Story? The Future of Ortho with The Fro
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Could CereVasc Be Boston’s Next Big MedTech Success Story? The Future of Ortho with The Fro
-
Narrated by:
-
By:
About this listen
In this episode of the DeviceTalks Weekly Podcast, Tom Salemi talks with seasoned MedTech executive Daniel Levangie about the blood-brain barrier-breaking technology being developed by CereVasc.
The company has developed a less invasive way of treating patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults. But the company’s tech gives physicians access to the brain, creating a potentially huge opportunity for future applications.
Just prior to the keynote interview, Tom talks with orthopedic surgeon and OrthoShow podcast host Scott Sigman, MD, about the Future of Orthopedics, a conversation they’ll resume at the start of DeviceTalks Boston.
Go to Boston.DeviceTalks.com to register to attend the April 30-May 1 conference. Use the code mentioned frequently in the podcast to save 25%.
But we’ll start off with MassDevice Editor Chris Newmarker’s Newsmakers - Abbott, Boston Scientific, Edwards Lifesciences, EBR Systems, and Johnson & Johnson MedTech.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.